Restructuring 23andMe: The High-Stakes Balance Between Finance and Data Protection
Complex Discovery
MARCH 24, 2025
Editor’s Note: 23andMes Chapter 11 filing marks a pivotal moment for both the company and the wider biotechnology sector. Despite raising $861 million and developing partnerships across the healthcare sector, the inability to achieve profitability has rendered its future precarious.
52 
Let's personalize your content